These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 17878638)
1. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations. Okawa M; Miwa H; Kajimoto Y; Hama K; Morita S; Nakanishi I; Kondo T Intern Med; 2007; 46(18):1527-31. PubMed ID: 17878638 [TBL] [Abstract][Full Text] [Related]
2. Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study. Alonso-Canovas A; Tembl Ferrairó JI; Martínez-Torres I; Lopez-Sendon Moreno JL; Parees-Moreno I; Monreal-Laguillo E; Pérez-Torre P; Toledano Delgado R; García Ribas G; Sastre Bataller I; Masjuan J; Martinez-Castrillo JC; Walter U Parkinsonism Relat Disord; 2019 Nov; 68():40-45. PubMed ID: 31621617 [TBL] [Abstract][Full Text] [Related]
3. Hyperechogenicity of the substantia nigra in Parkinson's disease. Ressner P; Skoloudík D; Hlustík P; Kanovský P J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838 [TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes. Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167 [TBL] [Abstract][Full Text] [Related]
6. Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study. Cardaioli G; Ripandelli F; Paolini Paoletti F; Nigro P; Simoni S; Brahimi E; Romoli M; Filidei M; Eusebi P; Calabresi P; Tambasco N Eur J Neurol; 2019 Nov; 26(11):1370-1376. PubMed ID: 31094036 [TBL] [Abstract][Full Text] [Related]
7. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no. Walter U J Neural Transm (Vienna); 2011 Apr; 118(4):607-12. PubMed ID: 21190047 [TBL] [Abstract][Full Text] [Related]
8. The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study). Prati P; Bignamini A; Coppo L; Naldi A; Comi C; Cantello R; Gusmaroli G; Walter U J Neural Transm (Vienna); 2017 Jul; 124(7):869-879. PubMed ID: 28451942 [TBL] [Abstract][Full Text] [Related]
9. Transcranial sonographic findings may predict prognosis of gastroprokinetic drug-induced parkinsonism. Oh YS; Kwon DY; Kim JS; Park MH; Berg D Parkinsonism Relat Disord; 2018 Jan; 46():36-40. PubMed ID: 29111425 [TBL] [Abstract][Full Text] [Related]
10. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes. Berg D J Neural Transm (Vienna); 2011 Apr; 118(4):613-9. PubMed ID: 21207077 [TBL] [Abstract][Full Text] [Related]
11. Transcranial sonography (TCS) in Parkinson's disease (PD) and essential tremor (ET) in relation with putative premotor symptoms of PD. Kim JS; Oh YS; Kim YI; Koo JS; Yang DW; Lee KS Arch Gerontol Geriatr; 2012; 54(3):e436-9. PubMed ID: 22277379 [TBL] [Abstract][Full Text] [Related]
12. [Transcranial sonography of substantia nigra in patients with Parkinson's disease]. Miwa H Rinsho Shinkeigaku; 2013; 53(11):981-2. PubMed ID: 24291852 [TBL] [Abstract][Full Text] [Related]
13. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI. Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136 [TBL] [Abstract][Full Text] [Related]
14. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease. van de Loo S; Walter U; Behnke S; Hagenah J; Lorenz M; Sitzer M; Hilker R; Berg D J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1087-92. PubMed ID: 20543186 [TBL] [Abstract][Full Text] [Related]
15. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia. Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033 [TBL] [Abstract][Full Text] [Related]
16. Midbrain transcranial sonography in Korean patients with Parkinson's disease. Kim JY; Kim ST; Jeon SH; Lee WY Mov Disord; 2007 Oct; 22(13):1922-6. PubMed ID: 17588240 [TBL] [Abstract][Full Text] [Related]
17. [Transcranial sonography (TCS) in evaluation of patients with essential tremor]. Budisić M; Trkanjec Z; Lovrencić-Huzjan A; Supanc V; Vuković V; Demarin V Acta Med Croatica; 2009 Dec; 63 Suppl 3():51-4. PubMed ID: 20232670 [TBL] [Abstract][Full Text] [Related]
18. [Transcranial parenchymal sonography in the diagnosis of Parkinson's disease]. Mijajlović M; Petrović I; Stojković T; Svetel M; Stefanova E; Kostić VS Vojnosanit Pregl; 2008 Aug; 65(8):601-5. PubMed ID: 18751340 [TBL] [Abstract][Full Text] [Related]
19. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study. Mahlknecht P; Seppi K; Stockner H; Nocker M; Scherfler C; Kiechl S; Willeit J; Schmidauer C; Gasperi A; Rungger G; Poewe W Neurodegener Dis; 2013; 12(4):212-8. PubMed ID: 23689066 [TBL] [Abstract][Full Text] [Related]
20. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]